Company / Accounts Receivable
LIFECORE BIOMEDICAL, INC. \DE\ Accounts Receivable History
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$69.6M
FY2019
5-year range
$46.2M / $69.6M
FY2015-FY2019
Trend
+29.1%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $46M to $70M over the past 2 years.
Based on SEC 10-K filings.
$70M in FY2019 with a 5-year CAGR of +9.4%.
Improved from $46M to $70M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +14.4%
- 5-Year CAGR
- +9.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +9.4%, indicating consistent growth.
- In FY2019, accounts receivable increased 29.1% year-over-year.
- Lowest accounts receivable in the period was in FY2012.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $69.6M | +29.1% |
| FY2018 | $53.9M | +16.1% |
| FY2017 | $46.4M | +0.0% |
| FY2016 | $46.4M | +0.5% |
| FY2015 | $46.2M | +3.9% |
| FY2014 | $44.4M | +23.1% |
| FY2013 | $36.1M | +12.9% |
| FY2012 | $32.0M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026